Tower Research Capital LLC (TRC) - C B PHARMA ACQUISITION CORP ownership

C B PHARMA ACQUISITION CORP's ticker is CNLM and the CUSIP is G2029P126. A total of 8 filers reported holding C B PHARMA ACQUISITION CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of C B PHARMA ACQUISITION CORP
ValueSharesWeighting
Q1 2016$3,000
+50.0%
303
+49.3%
0.00%
Q4 2015$2,000
+100.0%
203
+103.0%
0.00%
Q3 2015$1,000100
+426.3%
0.00%
Q2 2015$019
-5.0%
0.00%
Q1 2015$0200.00%
Other shareholders
C B PHARMA ACQUISITION CORP shareholders Q1 2016
NameSharesValueWeighting ↓
Weiss Asset Management LP 423,246$4,275,0001.06%
Polar Asset Management Partners Inc. 550,000$5,555,0000.24%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 350,000$3,535,0000.08%
Karpus Management, Inc. 131,601$1,329,0000.06%
AQR Arbitrage LLC 350,000$3,535,0000.04%
Yakira Capital Management, Inc. 12,500$126,0000.04%
Tower Research Capital LLC (TRC) 303$3,0000.00%
MORGAN STANLEY 9$00.00%
View complete list of C B PHARMA ACQUISITION CORP shareholders